BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25173391)

  • 1. Improvement of neurological dysfunctions in aphakia mice, a model of Parkinson's disease, after transplantation of ES cell-derived dopaminergic neuronal precursors.
    Chung S; Moon J; Kim KS
    Methods Mol Biol; 2014; 1213():285-91. PubMed ID: 25173391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.
    Moon J; Lee HS; Kang JM; Park J; Leung A; Hong S; Chung S; Kim KS
    Cell Transplant; 2013; 22(7):1263-79. PubMed ID: 23031199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Song B; Feldmann JW; Cao S; Feitosa M; Kong Y; Kim W; Schweitzer A; Leblanc P; Schweitzer JS; Kim KS
    Neurobiol Dis; 2022 Aug; 170():105777. PubMed ID: 35636646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease.
    Wang YK; Zhu WW; Wu MH; Wu YH; Liu ZX; Liang LM; Sheng C; Hao J; Wang L; Li W; Zhou Q; Hu BY
    Stem Cell Reports; 2018 Jul; 11(1):171-182. PubMed ID: 29910127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.
    Zenchak JR; Palmateer B; Dorka N; Brown TM; Wagner LM; Medendorp WE; Petersen ED; Prakash M; Hochgeschwender U
    J Neurosci Res; 2020 Mar; 98(3):458-468. PubMed ID: 29577367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson's Disease Model by Modulating Hippo Signaling.
    Choi J; Park SW; Lee H; Kim DH; Kim SW
    Tissue Eng Regen Med; 2024 Jul; 21(5):737-748. PubMed ID: 38600296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Substantia Nigra Is Permissive and Gains Inductive Signals When Lesioned for Dopaminergic Differentiation of Embryonic Stem Cells.
    Collazo-Navarrete O; Hernández-García D; Guerrero-Flores G; Drucker-Colín R; Guerra-Crespo M; Covarrubias L
    Stem Cells Dev; 2019 Aug; 28(16):1104-1115. PubMed ID: 31140356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
    Zygogianni O; Kouroupi G; Taoufik E; Matsas R
    Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
    Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
    Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
    J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host Microenvironment.
    Zuo FX; Bao XJ; Sun XC; Wu J; Bai QR; Chen G; Li XY; Zhou QY; Yang YF; Shen Q; Wang RZ
    Int J Mol Sci; 2015 Nov; 16(11):26473-92. PubMed ID: 26556344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease.
    Daadi MM; Grueter BA; Malenka RC; Redmond DE; Steinberg GK
    PLoS One; 2012; 7(7):e41120. PubMed ID: 22815935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.
    Yang F; Liu Y; Tu J; Wan J; Zhang J; Wu B; Chen S; Zhou J; Mu Y; Wang L
    Nat Commun; 2014 Dec; 5():5627. PubMed ID: 25517983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ES cell-derived renewable and functional midbrain dopaminergic progenitors.
    Chung S; Moon JI; Leung A; Aldrich D; Lukianov S; Kitayama Y; Park S; Li Y; Bolshakov VY; Lamonerie T; Kim KS
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9703-8. PubMed ID: 21606375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.